Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Colin Ng, MS

AtlasXomics, Connecticut, United States

Colin has extensive experience in commercialization, process development, and product management in the biotechnology field. As Vice President at AtlasXomics, he manages the commercialization of the first comprehensive spatial epigenome product on the market which currently servicing customers across academia and pharma. He was previously the VP of Consumable and Process Development at IsoPlexis Corporation, where he led the development, launch, and scaling of the IsoCode suite of products (IsoLight, IsoCode and IsoSpeak). This product is currently in over 100 labs across the globe and has led to over 70 publications in immune medicine. In addition, he established and led a contract research team that produced more than $3M in annual revenue through services provided to academic and industry leaders in immunooncology. After his time at IsoPlexis, Colin worked at Yale University, working closely with Yale faculty to raise seed financing for promising life science ventures.

Disclosure information not submitted.

Presentation(s):